← Career intelligence
Free · no sign-up · 3,138 priced deals

The deal tape

A precedent transactions set answers one question: what did somebody actually pay for a company like this one. Every row here is a US public target that filed a merger proxy or a going-private statement since 2020, with the offer per share, the premium to the unaffected price and the enterprise value multiples read from the filing itself rather than bought from a feed. Choose a sector, an industry code and a size band, and the quartiles above the list are the answer for that cut.

What it is not. Private-company deals, non-US targets and any transaction where no proxy was required leave nothing to read, so none of them are here. Neither are minority stakes or asset sales. Where a cross-check failed, the row still appears and says why, and it is held out of every median and quartile so one bad reading cannot move a number you would quote.

What this cut was bought at

Each measure counts the readings that survive its own cross-checks. Fewer than 4 is a coincidence, not a market.

MeasureDeals25thMedian75th
EV / LTM EBITDA0Too thin to quote. Widen the cut.
EV / LTM revenue0Too thin to quote. Widen the cut.
Premium to unaffected price25215%27%39%
Premium to 30-day VWAP3315%21%30%

Read the EBITDA multiple against the revenue multiple before you use either. Where they disagree sharply the target was priced on growth rather than earnings, and the EBITDA line is the one that will not survive a second question.

Deals by year of announcement
030592009: 2 deals, 0 clean on every measure200922010: 19 deals, 0 clean on every measure2010192011: 16 deals, 0 clean on every measure2011162012: 36 deals, 0 clean on every measure2012362013: 30 deals, 0 clean on every measure2013302014: 59 deals, 0 clean on every measure2014592015: 56 deals, 0 clean on every measure2015562016: 51 deals, 0 clean on every measure2016512017: 54 deals, 0 clean on every measure2017542018: 56 deals, 0 clean on every measure2018562019: 55 deals, 0 clean on every measure2019552020: 41 deals, 0 clean on every measure2020412021: 57 deals, 0 clean on every measure2021572022: 36 deals, 0 clean on every measure2022362023: 34 deals, 0 clean on every measure2023342024: 25 deals, 0 clean on every measure2024252025: 47 deals, 0 clean on every measure2025472026: 25 deals, 0 clean on every measure202625
Clean on every measure In doubt on one measure or both
Median EV / LTM EBITDA by sector

No cut here holds enough clean readings to quote.

Deals by sector
Financials: 210 dealsFinancials210Healthcare: 79 dealsHealthcare79Energy: 66 dealsEnergy66Technology: 60 dealsTechnology60Real Estate: 55 dealsReal Estate55Industrials: 53 dealsIndustrials53Media & Telecom: 42 dealsMedia & Telecom42Consumer & Retail: 40 dealsConsumer & Retail40Business Services: 30 dealsBusiness Services30Other: 24 dealsOther24Utilities: 23 dealsUtilities23Materials: 17 dealsMaterials17
Deals by buyer type
Financial sponsor: 34 dealsFinancial sponsor34Strategic: 699 dealsStrategic699Management / founder: 1 dealsManagement / founder1Controlling holder: 0 dealsControlling holder0Acquisition vehicle: 0 dealsAcquisition vehicle0Unclassified: 280 dealsUnclassified280
Deals by enterprise value
Under $250m: 242 dealsUnder $250m242$250m to $1bn: 129 deals$250m to $1bn129$1bn to $5bn: 184 deals$1bn to $5bn184$5bn to $20bn: 109 deals$5bn to $20bn109Over $20bn: 33 dealsOver $20bn33Not computed: 2 dealsNot computed2
Deals by industry code
Depository Institutions: 171 dealsDepository Institutions171Chemicals, Pharmaceuticals & Allied Products: 56 dealsChemicals, Pharmaceutic…56Oil & Gas Extraction: 52 dealsOil & Gas Extraction52Business Services & Software: 49 dealsBusiness Services & Sof…49Holding & Other Investment Offices: 44 dealsHolding & Other Investm…44Communications: 32 dealsCommunications32Electronics & Electrical Equipment: 30 dealsElectronics & Electrica…30Instruments, Medical Devices & Optical Goods: 27 dealsInstruments, Medical De…27Industrial Machinery & Computers: 23 dealsIndustrial Machinery & …23Electric, Gas & Sanitary Services: 23 dealsElectric, Gas & Sanitar…23
TargetAcquirerIndustryEVEV / EBITDAEV / revenuePremiumFiling
Flushing Financial Corp
2025-12-29 · Public merger · $19.76 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM revenue 69.0x above 60x
OceanFirst Financial Corp.
Strategic
Financials$525mn.a.69.0x
n.a.
DEFM14A
Includes stock
LINKBANCORP, Inc.
2025-12-18 · Public merger · $7.95 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Burke & Herbert
Strategic
Financials$206mn.a.1.1x
n.a.
DEFM14A
Includes stock
Two Harbors Investment Corp.
2025-12-17 · Public merger · $15.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
UWM Acquisitions 1, LLC
Strategic
Real Estate$9.2bnn.a.n.a.
n.a.
DEFM14A
Includes stock
Green Dot Corp
2025-11-23 · Public merger · $8.11 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM EBITDA -10.0x outside 1x to 75x
Compass Sub North, Inc.
Strategic
Financials-$1.2bn-10.0x-0.6x
n.a.
DEFM14A
Includes stock
Exact Sciences Corp
2025-11-19 · Public merger · $105.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Abbott Laboratories
Strategic
Healthcare$19bnn.a.6.1x
51%
DEFM14A
Includes stock
CNL Healthcare Properties, Inc.
2025-11-04 · Public merger · $2.32 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
SSL Sparti LLC
Strategic
Real Estate$914m10.7x2.6x
n.a.
DEFM14A
Includes stock
Kenvue Inc.
2025-11-02 · Public merger · $3.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Vesta Sub I, Inc.
Strategic
Materials$6.3bn2.1x0.4x
8%
DEFM14A
Includes stock
Civitas Resources, Inc.
2025-11-02 · Public merger · $3.77 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
SM Energy
Strategic
Energy$5.4bnn.a.1.1x
n.a.
DEFM14A
Includes stock
REV Group, Inc.
2025-10-29 · Public merger · $8.71 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Terex Corporation
Strategic
Industrials$479m2.5x0.2x
n.a.
DEFM14A
Includes stock
Olympic Steel Inc
2025-10-28 · Public merger · $39.26 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Crimson MS Corp.
Strategic
Industrials$673m9.7x0.3x
32%
DEFM14A
Includes stock
Sonnet BioTherapeutics Holdings, Inc.
2025-10-27 (filed) · Public merger · $1.25 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Biosub Inc.
Strategic
Healthcare$25mn.a.0.6x
n.a.
DEFM14A
Includes stock
Avidity Biosciences, Inc.
2025-10-25 · Public merger · $72.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM revenue 426.4x above 60x
Distribution Agreement
Strategic
Healthcare$8.9bnn.a.426.4x
46%
DEFM14A
Includes stock
Comerica Inc
2025-10-05 · Public merger · $82.88 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Fifth Third Bancorp
Strategic
Financials$11bnn.a.14.8x
n.a.
DEFM14A
Includes stock
Veeco Instruments Inc
2025-09-30 · Public merger · $10.15 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Axcelis Technologies, Inc.
Strategic
Industrials$467m7.5x0.7x
15%
DEFM14A
Includes stock
RTB Digital, Inc.
2025-09-28 · Public merger · $130.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
RYVYL, Inc.
Strategic
Business Services$4.1bnn.a.n.a.
n.a.
DEFM14A
Includes stock
Semler Scientific, Inc.
2025-09-22 · Public merger · $80.71 a share
Held out of every statistic: consideration includes stock: the cash figure is not the price; premium of 157%: distressed or misread
Strive, Inc.
Strategic
Healthcare$1.2bnn.a.27.5x
157%
DEFM14A
Includes stock
Berry Corp (bry)
2025-09-14 · Public merger · $3.81 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
California Resources Corporation
Strategic
Energy$686mn.a.1.0x
15%
DEFM14A
Includes stock
Evofem Biosciences, Inc.
2025-09-08 (filed) · Public merger · $116.75 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price; EV / LTM revenue 74.5x above 60x
Adifem, Inc.
Strategic
Healthcare$1.3bnn.a.74.5x
65%
DEFM14A
Includes stock
Vital Energy, Inc.
2025-08-24 · Public merger · $18.95 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Crescent Energy Company
Strategic
Energy$3.0bn24.7x1.6x
n.a.
15% to VWAP
DEFM14A
Includes stock
Hanesbrands Inc.
2025-08-13 · Public merger · $0.80 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Gildan Activewear Inc.
Strategic
Consumer & Retail$2.4bn5.0x0.7x
42%
DEFM14A
Includes stock
Steelcase Inc
2025-08-03 · Public merger · $7.20 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
HNI Corporation
Strategic
Consumer & Retail$1.0bn4.3x0.3x
13%
DEFM14A
Includes stock
CoreCard Corp
2025-07-30 · Public merger · $4.50 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Euronet Worldwide, Inc.
Strategic
Technology$3mn.a.0.0x
n.a.
DEFM14A
Includes stock
Norfolk Southern Corp
2025-07-28 · Public merger · $88.82 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Union Pacific
Strategic
Industrials$36bn5.6x3.0x
n.a.
25% to VWAP
DEFM14A
Includes stock
Chart Industries Inc
2025-07-28 · Public merger · $210.00 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
Baker Hughes Company
Strategic
Industrials$13bn13.2x3.0x
30%
DEFM14A
Includes stock
Core Scientific, Inc./tx
2025-07-07 · Public merger · $5.75 a share
Held out of the multiples: consideration includes stock: the cash figure is not the price
CoreWeave, Inc., Inc.
Strategic
Financials$1.1bnn.a.3.3x
57%
DEFM14A
Includes stock

How to use a set like this

Cut to the narrowest set that still holds eight or ten deals, then quote the range rather than the median. An interviewer who asks where software takes out will accept a spread and press on a single number, because the single number implies a precision the set does not have. Say which deals sit at each end and why: the top of a range is usually a contested auction or a strategic buyer with synergies, the bottom a controlling holder buying in the minority.

Premiums move with the reference price, not only with the deal. A bidder quotes the period that flatters the offer, so read the premium to the unaffected close beside the premium to the thirty-day average and notice when they diverge.

What each column means

Enterprise value.
Offer per share times shares outstanding, plus net debt at the last balance sheet before the merger agreement. It is blank where either piece was missing, and those rows are in the “not computed” band rather than in a size they never earned.
Premium.
The offer against the unaffected price, which is the last close before the deal became known. Where the filing states a premium to the thirty-day volume-weighted average, that is shown next to it.
Deal type.
A take-private is bought by an affiliate, which is what triggers the Schedule 13E-3 and the fuller disclosure that comes with it. A public merger is an arm’s-length buyer, disclosed through the merger proxy.
In doubt.
A cross-check the reading could not satisfy: an equity value far from the fee-table figure, a multiple outside any sane band, or consideration that is partly stock so the per-share cash figure is not the price. The row stays visible, and it is set aside only for the measures the doubt reaches. A cash-and-stock deal cannot price a multiple and still states a premium the filing itself computed, so it counts in one and not the other.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More